Dual Perspectives on DAPT
VIDEO: New cholesterol guidelines, risk calculator key to improving patient care
Lipid Forum II Highlights
Platelet Function and Genetic Testing: Current Status and Use
Cerebral protection with an investigational device designed to deflect debris away from the brain during transcatheter aortic valve replacement was safe at 30 days, according to new data presented at EuroPCR 2015.
Patients who underwent protected TAVR also had a higher rate of freedom from ischemic brain lesions, less neurologic deficit, and improved cognitive function at discharge and 30 days compared with patients who underwent TAVR without neuroprotection.
This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC
CVD prevention, treatment challenging as patients with HIV and HCV live longer
A tribute to Elijah Saunders, MD
A look at coagulation assays for target-specific oral anticoagulants
This feature offers timely executive summaries of the most relevant journals in cardiology.
Snapshot summaries of recent study results in cardiology.
Your central portal for information presented at ACC 2015.
Your resource for news and videos from SCAI 2014.
This exclusive Healio resource provides you a comprehensive window into what your colleagues and key opinion leaders are saying about current and future drugs and devices and their impact on patient outcomes.
Related story »
View past polls »
Search Healio's robust listing of national and international medical meetings.
©2015 All Rights Reserved.